Acute myelogenous leukemia subsequent to therapy for a different neoplasm: Clinical features and response to therapy

The clinical characteristics of 10 patients with acute myelogenous leukemia (AML) which developed subsequently to treatment for another neoplasm are described. This disease appears to differ from “spontaneous” AML in being associated with lesser degrees of leukemic infiltration of the marrow and more frequent chromosomal aberrations. Only one of the nine patients who received chemotherapy attained remission status, and the mean and median survivals from the initiation of chemotherapy were 2.7 months and one month respectively. Nine of the 10 patients died as a result of infection. The refractoriness of this form of AML to chemotherapy was borne out by a review of the literature, which revealed only two remissions in 32 treated patients. The implications for the management of this disease are discussed.

[1]  E. Andersen,et al.  Stem cell leukaemia in myelomatosis. , 2009, Scandinavian journal of haematology.

[2]  K. Rai,et al.  Acute myelocytic leukemia. , 1976, Archives of internal medicine.

[3]  S. Hellman,et al.  Limited proliferation of stem cells surviving alkylating agents , 1976, Nature.

[4]  H. Preisler,et al.  Protected environment units in the treatment of acute leukemia. , 1975, Seminars in oncology.

[5]  D. Hossfeld,et al.  Chromosome studies in acute leukemias developing in patients with multiple myeloma. , 1975, Cancer research.

[6]  F. Rosner,et al.  Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature. , 1975, The American journal of medicine.

[7]  P. Jacobs,et al.  ACUTE LEUKÆMIA AND MYELOMA , 1974 .

[8]  H. Al-Mondhiry,et al.  Acute leukemia in Hodgkin's disease , 1974, Cancer.

[9]  W. Larsen,et al.  Alkylating agents as leukemogens in multiple myeloma , 1974, Cancer.

[10]  J. Hamers,et al.  [Acute leukemia in a case of multiple myeloma]. , 1973, Nederlands tijdschrift voor geneeskunde.

[11]  J. Hamers,et al.  Acute leukaemia in myeloma. , 1973, Lancet.

[12]  L. Pechet,et al.  Leukemia after chemotherapy of Hodgkin's disease. , 1973, The New England journal of medicine.

[13]  V. Devita,et al.  Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy. , 1972, The New England journal of medicine.

[14]  G. Kanzler,et al.  [Leukemia in Hodgkin's disease due to cancerostatic therapy?]. , 1972, Medizinische Klinik.

[15]  R. Kyle,et al.  Multiple myeloma and acute myelomonocytic leukemia. , 1970, The New England journal of medicine.

[16]  E. G. Harrison,et al.  Myelomonocytic leukemia in Hodgkin's disease , 1970, Cancer.

[17]  A. Sandberg,et al.  Myeloid leukemia in Hodgkin's disease: chromosomal abnormalities. , 1969, Annals of internal medicine.

[18]  J. Durant,et al.  COEXISTENT DiGUGLIELMO'S LEUKEMIA AND HODGKIN'S DISEASE: A Case Report with Cytogenetic Studies , 1967, The American journal of the medical sciences.

[19]  Y. S. Sathe,et al.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. , 1966, Annals of internal medicine.

[20]  E. Henderson,et al.  Adriamycin-cytosine arabinoside therapy for adult acute myelocytic leukemia. , 1977, Cancer treatment reports.

[21]  B. Speck,et al.  Acute myelomonocytic leukemia in a patient with Hodgkin's disease. , 1973, Acta haematologica.

[22]  G. R. Lee,et al.  Sideroblastic anemia in multiple myeloma: a preleukemic change. , 1973, Blood.